Complex chemistry at Sterling

Increasing interest in targeted treatments, coupled with the prevalence of small molecules in treating common indications, has led to more biotechnology and pharmaceutical organisations developing complex molecules than ever before.
With these complex molecules comes a whole new set of challenges to navigate, like funding, hazardous chemistry, approval rates, specialised technologies, and more. How can you successfully harness complex chemistry as you develop your innovative therapeutic?